ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IGC IGC Pharma Inc

0.4904
-0.0296 (-5.69%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
IGC Pharma Inc AMEX:IGC AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0296 -5.69% 0.4904 0.535 0.5081 0.5111 293,702 00:53:21

Current Report Filing (8-k)

18/04/2022 10:24pm

Edgar (US Regulatory)




UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):  April 13, 2022

 

indiaglob20220418_8kimg001.gif

 

India Globalization Capital, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Commission File Number: 001-32830

 

Maryland

20-2760393

(State or other jurisdiction of incorporation)

(I.R.S Employer Identification Number)

 

10224 Falls Road, Potomac, Maryland 20854

(Address of principal executive offices) (Zip code)

 

Registrant’s telephone number, including area code: (301) 983-0998

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the follow provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.01 par value

IGC

NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1934 (§240.12b-2 of this chapter)

Emerging growth company ☐.

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

CURRENT REPORT ON FORM 8-K

India Globalization Capital, Inc.

 

Item 8.01.

Other Events.

 

On April 18, 2022, India Globalization Capital, Inc. (the “Company”) distributed a press release to announce that on April 13, 2022, at the final settlement approval hearing, the United States District Court for the District of Maryland issued an order granting final approval of the settlement and dismissing the Tchatchou and Harris-Carr litigation. The settlement and related dismissal resolve all shareholder class action lawsuits pending against the Company and its officers.

 

Additional information regarding the terms of settlement can be found on the Company’s February 10, 2022 Form 10-Q.

 

The Company’s press release announcing approval of the settlement agreement is included as Exhibit 99.1 to this report.

 

 

Item 9.01.

Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.

Description

   

99.1 

Press Release Dated April 18, 2022

104

Cover Page Interactive Data File (formatted as Inline XBRL)

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

INDIA GLOBALIZATION CAPITAL, INC.

 
   

Date:  April 18, 2022

By:

/s/  Claudia Grimaldi

 
   

Claudia Grimaldi

 
   

Vice President, CCO and PFO

 

 

 

 

 

 
false 0001326205 0001326205 2022-04-13 2022-04-13

1 Year IGC Pharma Chart

1 Year IGC Pharma Chart

1 Month IGC Pharma Chart

1 Month IGC Pharma Chart

Your Recent History

Delayed Upgrade Clock